Motus GI Holdings found using ticker (MOTS) have now 6 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The range between the high target price and low target price is between 3 and 2 calculating the mean target price we have 2.5. With the stocks previous close at 0.97 this would imply there is a potential upside of 157.7%. The 50 day MA is 0.9 and the 200 day moving average is 1.05. The company has a market capitalisation of $32m. Company Website: http://www.motusgi.com
Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.
